Timolol prevents cell stress

Article

Glaucoma medication timolol exerts a direct antioxidant effect, protecting human endothelial cells from oxidative stress.

Glaucoma medication timolol exerts a direct antioxidant effect, protecting human endothelial cells from oxidative stress, according to a paper printed online ahead of publication in Eye.

Segio Sacca and colleagues from the University of Genoa and St Martino Hospital, Genoa, Italy induced oxidative stress in cultures of human endothelial cells using iron/ascorbate with or without timolol pre-treatment. Parameters for analysis included cell viability (neutral red uptake and tetrazolium salt tests), lipid peroxidation (thiobarbituric reactive substances) and occurrence of molecular oxidative damage to DNA (8-hydroxy-2'-deoxyguanosine).

Researchers founds that oxidative stress caused a 1.8-fold decrease in cell viability, a 3.0-fold increase in lipid peroxidation and a 64-fold increase in oxidative damage to DNA. In the presence of timolol, oxidative stress did not modify cell viability, whereas lipid peroxidation was increased 1.3-fold and DNA oxidative damage 3.6-fold.

The researchers concluded that timolol does exert a direct antioxidant effect that protects human endothelial cells from oxidative stress.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.